These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 15806172)
1. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Ledl A; Schmidt D; Müller S Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172 [TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Dick FA; Sailhamer E; Dyson NJ Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361 [TBL] [Abstract][Full Text] [Related]
3. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1. Alevizopoulos K; Sanchez B; Amati B Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468 [TBL] [Abstract][Full Text] [Related]
4. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Lee JO; Russo AA; Pavletich NP Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340 [TBL] [Abstract][Full Text] [Related]
5. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Brokaw JL; Yee CL; Münger K Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265 [TBL] [Abstract][Full Text] [Related]
6. Cellular proteins that are targetted by DNA tumor viruses for transformation. Dyson N; Buchkovich K; Whyte P; Harlow E Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911 [TBL] [Abstract][Full Text] [Related]
8. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Massimi P; Pim D; Storey A; Banks L Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772 [TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. Singh M; Krajewski M; Mikolajka A; Holak TA J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215 [TBL] [Abstract][Full Text] [Related]
10. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7. Chemes LB; Sánchez IE; Smal C; de Prat-Gay G FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein. Gagrica S; Hauser S; Kolfschoten I; Osterloh L; Agami R; Gaubatz S EMBO J; 2004 Nov; 23(23):4627-38. PubMed ID: 15538385 [TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation. Marcos-Villar L; Gallego P; Muñoz-Fontela C; de la Cruz-Herrera CF; Campagna M; González D; Lopitz-Otsoa F; Rodríguez MS; Rivas C Oncogene; 2014 Jan; 33(4):495-503. PubMed ID: 23318443 [TBL] [Abstract][Full Text] [Related]
13. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells. Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882 [TBL] [Abstract][Full Text] [Related]
14. RB family tumor suppressor activity may not relate to active silencing of E2F target genes. Vormer TL; Wojciechowicz K; Dekker M; de Vries S; van der Wal A; Delzenne-Goette E; Naik SH; Song JY; Dannenberg JH; Hansen JB; Te Riele H Cancer Res; 2014 Sep; 74(18):5266-76. PubMed ID: 25056122 [TBL] [Abstract][Full Text] [Related]
15. Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125). Krucher NA; Zygmunt A; Mazloum N; Tamrakar S; Ludlow JW; Lee MY Oncogene; 2000 Nov; 19(48):5464-70. PubMed ID: 11114723 [TBL] [Abstract][Full Text] [Related]
16. [Histone deacetylase and retinoblastoma protein]. Magnaghi-Jaulin L; Groisman R; Naguibneva I; Robin P; Trouche D; Harel-Bellan A Bull Cancer; 1998 Jul; 85(7):606-7. PubMed ID: 9752266 [TBL] [Abstract][Full Text] [Related]
17. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696 [TBL] [Abstract][Full Text] [Related]
18. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Chan HM; Smith L; La Thangue NB Oncogene; 2001 Sep; 20(43):6152-63. PubMed ID: 11593423 [TBL] [Abstract][Full Text] [Related]
19. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Fan S; Yuan R; Ma YX; Xiong J; Meng Q; Erdos M; Zhao JN; Goldberg ID; Pestell RG; Rosen EM Oncogene; 2001 Aug; 20(35):4827-41. PubMed ID: 11521194 [TBL] [Abstract][Full Text] [Related]
20. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway. McCabe MT; Low JA; Imperiale MJ; Day ML Oncogene; 2006 May; 25(19):2727-35. PubMed ID: 16547506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]